Vernalis Announces Successful Study With CCP-01

(firmenpresse) - WINNERSH, UNITED KINGDOM -- (Marketwired) -- 11/25/13 --





Contacts:
RNS
Customer
Services
0044-207797-4400

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 25.11.2013 - 07:09 Uhr
Sprache: Deutsch
News-ID 319783
Anzahl Zeichen: 0

contact information:
Town:

WINNERSH, UNITED KINGDOM

Kategorie:

Commercial & Investment Banking

Diese Pressemitteilung wurde bisher 181 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Vernalis Announces Successful Study With CCP-01"
steht unter der journalistisch-redaktionellen Verantwortung von

Vernalis PLC (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).

Vernalis plc: Results Announcement for the year ended 30 June 2017 ...

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 09/12/17 -- Vernalis PLC (LSE: VER) (OTC PINK: VNLPY)12 September 2017 LSE: VERTuzistra® XR prescriptions growing steadily In-house salesforce to promote both Tuzistra® XR and Moxatag® for the coming s ...

Vernalis PLC: FDA Issues Complete Response Letter on CCP-08 NDA ...

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 08/07/17 -- Vernalis PLC (LSE: VER)07 August 2017LSE: VERVernalis plc announced today that the US Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding the New Drug Appl ...

Vernalis PLC: Year-End Trading Update and Notice of Full Year Results ...

WINNERSH, UNITED KINGDOM -- (Marketwired) -- 07/18/17 -- Vernalis PLC (LSE: VER)18 July 2017 LSE: VERContinued steady growth of Tuzistra® XR annualised prescription run rate through drug's second cough cold season; similar growth rate expected ...

Alle Meldungen von Vernalis PLC